- Home
- TURN vs SCNX Comparison
TURN vs SCNX Comparison
Compare TURN & SCNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TURN
- SCNX
- Stock Information
- Founded
- TURN 1981
- SCNX 2010
- Country
- TURN United States
- SCNX United States
- Employees
- TURN N/A
- SCNX N/A
- Industry
- TURN Finance/Investors Services
- SCNX Other Pharmaceuticals
- Sector
- TURN Finance
- SCNX Health Care
- Exchange
- TURN Nasdaq
- SCNX Nasdaq
- Market Cap
- TURN 49.6M
- SCNX 21.2M
- IPO Year
- TURN N/A
- SCNX 2020
- Fundamental
- Price
- TURN $4.96
- SCNX $0.89
- Analyst Decision
- TURN
- SCNX
- Analyst Count
- TURN 0
- SCNX 0
- Target Price
- TURN N/A
- SCNX N/A
- AVG Volume (30 Days)
- TURN 33.2K
- SCNX 475.0K
- Earning Date
- TURN 02-26-2018
- SCNX 11-05-2025
- Dividend Yield
- TURN N/A
- SCNX N/A
- EPS Growth
- TURN N/A
- SCNX N/A
- EPS
- TURN 0.29
- SCNX N/A
- Revenue
- TURN $488,011.00
- SCNX $128,202.00
- Revenue This Year
- TURN N/A
- SCNX N/A
- Revenue Next Year
- TURN N/A
- SCNX N/A
- P/E Ratio
- TURN $17.34
- SCNX N/A
- Revenue Growth
- TURN 277.43
- SCNX N/A
- 52 Week Low
- TURN $3.12
- SCNX $0.69
- 52 Week High
- TURN $5.01
- SCNX $9.55
- Technical
- Relative Strength Index (RSI)
- TURN 86.44
- SCNX 33.14
- Support Level
- TURN $7.73
- SCNX $0.86
- Resistance Level
- TURN $8.74
- SCNX $1.16
- Average True Range (ATR)
- TURN 0.25
- SCNX 0.08
- MACD
- TURN 0.36
- SCNX 0.02
- Stochastic Oscillator
- TURN 77.78
- SCNX 16.57
About TURN 180 Degree Capital Corp.
180 Degree Capital Corp is active in the financial services domain. It is a non-diversified closed-end management investment company whose objective is to achieve long-term capital appreciation by making venture capital investments. It focuses its investments on companies commercializing and integrating products enabled by disruptive technologies mainly in the life sciences, precision medicine, and health industries.
About SCNX Scienture Holdings Inc. Common Stock
Scienture Holdings Inc is a comprehensive health services and pharmaceutical product company. The group focused on providing value to patients and caregivers by offering novel specialty products to satisfy unmet market needs and optimize the prescription journey and patient engagement in the U.S.